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Patient-Centric Healthcare Supply Chains in sub-Saharan Africa: State of the 
Art and Possible Implications 
 
 
Overview  
This paper addresses the following questions: 
 
1. What is the current State of the Art in terms of research into patient-centric 
healthcare supply chains? 
2. Based on the State of the Art and thought leadership in this area, what are 
some possible implications for the future in terms of drug product design, 
drug supply chain, ICT enablement and business models in the context of 
sub-Saharan Africa? 
 
The results of the reviews are presented in this paper under the following headings: 
 
• Executive summary 
• Introduction 
• Literature review and analysis questions 
• Patient-centric healthcare supply chains 
• Implications for the future in sub-Saharan Africa 
• Overall conclusions and recommendations 
• Bibliography 
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Executive Summary  
This review uses the results of a literature review into patient-centric healthcare 
supply chains as the basis for identifying implications for sub-Saharan Africa. 
Implications are identified in the areas of business models, ICT, drug design and 
drug supply chains. 
 
The primary conclusion is that internal and external pressures on healthcare supply 
chains in sub-Saharan Africa mean that change is required. The main 
recommendation is that research should be performed to improve the 
understanding of issues around patient adherence in resource-poor environments 
in sub-Saharan Africa as the basis for planning change. 
 
 
Introduction  
The twin purposes of this literature review assessment and analysis are to 
understand the current state of research into patient-centric healthcare supply 
chains, and to identify possible future implications on drug product design, drug 
supply chains, ICT enablement and business models in the context of sub-Saharan 
Africa. The review addresses the two purposes sequentially. 
 
First, the State of the Art of research into patient-centric healthcare supply chains is 
addressed. The literature review commences with a review of current topics in 
supply chain theory and practice and consumer centricity before focusing on 
healthcare supply chains. It then looks at research into patient centricity, and finally 
combines these to understand the current state of research into patient-centric 
healthcare supply chains. 
 
Second, the implications are considered. The context of sub-Saharan Africa is 
established first. Following this, the implications on the four specified areas are 
analysed. 
 
Finally, the broader implications of the two questions are considered together. 
 
The approach taken for the literature review has been advocated by Hagen-Zanker 
& Mallett (2013) of the Overseas Development Institute (ODI) think tank. They 
propose a reflexive method that includes 3 “tracks” of information retrieval: 
academic literature, “snowballing”, and “grey literature”. “Snowballing” refers to 
the process of actively seeking out additional material through use of references in 
key publications and by consulting experts for their guidance on important papers. 
These introduce an element of subjectivity in the selection of material but give a 
sense of which literature has been influential in the field. “Grey literature” means 
non-peer reviewed material, which in this study included articles and reports from 
Non-Governmental Organisations (NGOs) and donors, reports and policy 
documents from the United Nations and other official Governmental publications, 
articles and editorials published in trade magazines and journals, and corporate 
documents. Inclusion of grey literature must be done with care because of the 
potential for variable quality, but it can increase the breadth, relevance and value 
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of the final review and is particularly recommended for research in International 
Development. In the case of healthcare supply chains in sub-Saharan Africa, the 
inclusion of non-academic material is especially valuable because of the paucity of 
peer-reviewed academic research. 
 
 
Literature Review and Analysis Questions  
The two questions composing the assessment and analysis are: 
1. What is the current State of the Art in terms of research into patient-centric 
healthcare supply chains? 
2. Based on the State of the Art and thought leadership in this area, what are 
some possible implications for the future in terms of drug supply chain, drug 
product design, ICT enablement and business models in the context of sub-
Saharan Africa? 
The questions will be considered separately and then the results combined. 
 
 
1. Patient-centric healthcare supply chains 
This section addresses the first question, namely: 
What is the current State of the Art in terms of research into patient-centric 
healthcare supply chains? 
 
The section looks in turn at supply chains and customer centricity in general, before 
moving on to consider healthcare supply chains, patient centricity and finally 
patient-centric healthcare supply chains. A conclusion identifies the key areas that 
then feed into the analysis for the second question. 
 
Current topics in supply chain theory and practice 
“The supply chain — a term now commonly used internationally — encompasses 
every effort involved in producing and delivering a final product or service, from 
the supplier's supplier to the customer's customer.” 
 
This definition of the term “supply chain”, quoted by Lummus & Vokurka (1999), 
originated from the Supply Chain Council (SCC 2012). The SCC is a global non-profit 
organisation that exists to help its members improve the performance of their 
supply chains. It was established in 1996 to define and promote best practice in 
supply chain management (SCM). Its Supply Chain Operations Reference (SCOR) 
process reference model is considered within manufacturing industry to embody 
supply chain management’s state of the art. The SCC now has almost 1000 
companies as corporate members. 
The term “supply chain management” (SCM) is used in academia and business to 
refer to the management processes governing supply chains. It was introduced by 
Oliver & Webber in 1982. A second industry body, a professional institute called 
The Council of Supply Chain Management Professionals, was founded in 1963 and 
represents SCM practitioners in 67 countries. It defines SCM as follows: 
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“Supply Chain Management encompasses the planning and management of all 
activities involved in sourcing and procurement, conversion, and all Logistics 
Management activities. Importantly, it also includes coordination and collaboration 
with channel partners, which can be suppliers, intermediaries, third-party service 
providers, and customers. In essence. Supply Chain Management integrates supply 
and demand management within and across companies” (CSCMP 2013, quoted in 
Gibson et al. 2005)." 
 
To achieve a broad perspective quickly, a review of literature reviews was 
performed. This allowed this review to build on the consolidations and conclusions 
of other experts, and then to provide its own holistic analysis to reach a perspective 
on current topics. 
 
In line with the stated method, a search of EBSCO and JSTOR databases for the 
terms “supply chain” and “literature review” in the title published since 2000 listed 
20 papers which were then supplemented with 21 further recommended and 
relevant papers to give a list of 41 documents. The approach was not necessarily 
comprehensive in terms of incorporating every document but aimed to be so for 
the major themes. 
 
The 22 journals contributing to the study are listed in Table 1. 
 
 
Table 1: Journals contributing to the review 
 
Journal 
abbreviation 
Count Journal full name 
BH 1 Business History 
CII 1 Computers In Industry 
CSREM 1 Corporate Social Responsibility and Environmental Management 
EJM 1 European Journal of Marketing 
EJPSM 2 European Journal of Purchasing & Supply Management 
ESA 1 Expert Systems with Applications 
GJFSM 1 Global Journal of Flexible Systems Management 
IJLM 3 The International Journal of Logistics Management 
IJOPM 4 International Journal of Operations & Production Management 
IJPDLM 1 International Journal of Physical Distribution & Logistics Management 
IJPE 2 International Journal of Production Economics 
IJPPM 2 International Journal of Productivity & Performance Management 
IJPR 3 International Journal of Production Research 
IMDS 3 Industrial Management & Data Systems 
JAMS 1 Journal of the Academy of Marketing Science 
JBL 2 Journal of Business Logistics 
JMPP 1 Journal of Management Policy and Practice 
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Journal 
abbreviation 
Count Journal full name 
JMTP 1 Journal of Marketing Theory and Practice 
JSCM 1 Journal of Supply Chain Management 
PPC 1 Production Planning & Control 
SCMIJ 7 Supply Chain Management: An International Journal 
TR pt E 1 Transportation Research Part E 
 
 
The 41 documents used in the supply chain literature review are listed in Table 2, 
along with the main conclusions drawn from each document. Grey literature was 
then introduced in subsequent healthcare-related sections where less research has 
been performed, complementing the academic papers. 
 
 
Table 2: Literature included in the Review 
 
Journal Reference Topic Themes and conclusions 
JMTP Larson & Rogers 
1998 
SCM definition Development of the term SCM 
IJOPM New 1996 Supply chain 
improvement 
Supply chain focuses on “effective purchasing 
and distribution”, “long-term relationships 
between trading partners”, and “operational 
integration of trading partners” 
IJLM Bechtel & 
Jayaram 1997 
SCM Strategic aspects of SCM 
IJLM Cooper et al. 
1997 
SCM and 
logistics 
SCM: coordination between supply chain 
partners is more than just logistics 
IJLM Lambert et al. 
1998 
Implementing 
SCM 
Successful implementation of SCM 
IMDS Lummus & 
Vokurka 1999 
SCM Development of the term SCM. Guidance on SCM 
EJPSM Croom et al. 2000 SCM analytical 
framework 
Literature categorisation. Noted a lack of 
theoretical SCM work 
EJPSM Tan 2001 SCM analytical 
framework 
SCM’s aim is “waste elimination and increased 
efficiency” 
IMDS Lummus et al. 
2001 
SCM and 
logistics 
SCM and logistics are often confused. A 
commonly agreed understanding is necessary 
JBL Mentzer et al. 
2001 
SCM SCM is “to deliver lower costs, increased 
customer value and satisfaction, and competitive 
advantage” 
IJPDLM Svensson 2002 SCM and 
marketing 
“The theoretical foundations of SCM are derived 
from… the functionalist theory of marketing” 
TR pt E Meixell & 
Gargeya 2005 
Supply chain 
design 
Supply chain models must take account of 
manufacturing locations and support multiple 
tiers. Performance measures must address 
alternative objectives. More industries must be 
investigated in the context of global supply chain 
JBL Gibson et al. 2005 SCM How the CSCMP definition of SCM was achieved 
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Journal Reference Topic Themes and conclusions 
IJOPM Burgess et al. 
2006 
SCM SCM is a “young” research field. “Exponential 
growth” in research. “The robustness of the ideas 
underpinning SCM have not been fully tested”. A 
“need to move beyond positivist methods of 
research” 
IJPE Vonderembse et 
al. 2006 
Supply chain 
theory 
development 
Standard products should use lean supply chain; 
innovative products (“adaptable to changing 
customer requirements”) should use agile supply 
chain. Hybrid supply chain with delayed 
customisation (postponement) can add 
innovative elements to standard products 
IJOPM Storey et al. 2006 SCM theory 
development 
“Substantial gaps between theory and practice”. 
Who should manage the supply chain? 
SCMIJ Halldorsson et al. 
2007 
SCM theory 
development 
There is no unified theory of SCM but different 
ones can be chosen depending on the situation 
IJPR Gunasekaran & 
Kobu 2007 
Supply chain  
performance 
measurement 
“Customer satisfaction has not been given due 
consideration in measuring the performance of 
supply chain” 
JSCM Borade & Bansod 
2008 
SCM “Researchers should make an industry-centric 
research to explore the full potential of SCM” 
GJFSM Siddiqui et al. 
2009 
SCM in 
context of 
Total Quality 
Management 
Flexibility is important: “reasonably priced 
customised products of high quality that can be 
quickly delivered to customers” 
EJM Athanasopoulou 
2009 
Relationship 
quality 
RQ: “trust, commitment, satisfaction”. “The role 
of the environment is neglected”. There is “no 
accepted framework” for research 
IMDS Hilletofth 2009 Supply chain 
strategy 
Two case studies show the possibility of 
combining different supply, manufacturing and 
distribution strategies 
BH Alfalla-Luque & 
Medina-López 
2009 
SCM 
development 
Research is developing rapidly but more research 
is required 
JAMS Stock & Boyer 
2009 
SCM definition “There is too much disagreement as to what SCM 
is and what functions and/or processes it 
includes” 
CSREM Gold et al. 2010 Sustainable 
supply chain 
“Collaborative paradigm” emerged as a result of 
environmental concerns driving supply chains to 
act as “meta-organisations” 
IJPR Arzu Akyuz & 
Erman Erkan 
2010 
Supply chain 
performance 
measurement 
Balanced Scorecard and SCOR model are 
important. Frameworks and models are 
immature. More research on metrics/KPIs 
JMPP Naslund & 
Williamson 2010 
SCM definition SCM is complex and still poorly defined 
SCMIJ Delbufalo 2012 Inter-
organisational 
trust 
“Supply chains need to align their constituent 
companies to become more customer-oriented 
and deliver increased levels of customer value” 
SCMIJ Gligor & Holcomb 
2012 
Supply chain 
agility 
Increasing demand for agility. Logistics can 
contribute 
IJPE Hassini et al. 2012 Sustainable Needs industry-specific research. No research 
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Journal Reference Topic Themes and conclusions 
supply chain found linking inventory management with 
sustainability 
CII Zeng et al. 2012 Secure 
collaboration 
Secure collaboration is vital. The issue is the need 
to simultaneously share and protect information 
in cooperation/competition situations 
ESA Marra et al. 2012 Knowledge 
management 
“Knowledge management is a tool for supply 
chain integration”. Knowledge flow between 
partners is important but needs more research 
IJPPM Gopal & Thakkar 
2012 
Supply chain 
performance 
measurement 
Improvement in metrics over the last decade, eg. 
six-sigma, SCOR, KPIs. Need evidence of impact 
on performance of concepts like knowledge 
management 
SCMIJ Miemczyk et al. 
2012 
Sustainable 
supply chain 
More focus on environmental sustainability than 
social sustainability, eg. social equity, ethics, 
health & safety, community. How can eg. NGOs 
contribute? 
IJPR Simangunsong et 
al. 2012 
Supply chain 
uncertainty 
14 sources of uncertainty identified, and 2 
approaches: reducing and coping. ICT important 
for reducing. Coping strategies include 
postponement, flexibility, buffer stock, analytics 
SCMIJ Ashby et al. 2012 Sustainable 
supply chain 
Literature tends to focus on processes and “hard 
quantifiable elements” 
SCMIJ Fayezi et al. 2012 Agency theory Can be applied to information sharing, shared 
risk/reward, supply chain communication, and 
relationship maintenance 
SCMIJ Wong et al. 2012 Supply chain 
alignment 
“Supply chain has to be aligned to deliver 
customer value, measured in terms of customer-
perceived benefits gained”. 6 enablers of 
alignment identified including customer 
relational behaviour 
PPC Alfalla-Luque et 
al. 2013 
Supply chain 
integration 
Dimensions of integration: “information 
integration, coordination and resource sharing, 
and organisational relationship linkage” 
IJOPM Shi & Yu 2013 Financial 
performance 
ICT and external relationships are factors shown 
to improve supply chain performance 
IJPPM Taticchi et al. 
2013 
Sustainable 
supply chain 
Increasing focus on performance measurement 
of sustainable supply chain. Little focus on 
measuring social performance. North America 
and Europe are the focuses of research 
 
Conclusions arising from this analysis include: 
• There has been a dramatic increase in supply chain literature reviews during 
the period. This probably reflects increasing interest in, importance of, and 
maturity of, the field 
• Nevertheless SCM is still considered to be an immature research field. There 
is no single theory of SCM, nor are the various underpinning theories 
mature or fully tested. There is a need to do more qualitative research as 
well as just quantitative research 
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• There are gaps between supply chain theory and practice. For example, the 
theory of end-to-end management of a supply chain is not easily translated 
into practice 
• Sustainability and environmental concerns were covered by 5 literature 
reviews. These topics are considered to be driving closer supply chain 
partnerships. However, there is a recommendation that social sustainability 
should be a stronger focus of research, not just environmental sustainability 
• Inter-organisational integration and alignment are the subject of 4 literature 
reviews. Supply chain partners face the challenge of sharing information in a 
way which exposes enough to make collaboration possible but without 
sharing too much with partner companies that are also potential or actual 
competitors 
• Performance is also the subject of 4 literature reviews. One 
recommendation is that performance measurement should take greater 
account of customers and customer satisfaction 
• It is recognised that supply chains must become more customer-oriented 
and deliver better value propositions to customers 
• Implementation of Information & Communications Technology (ICT) has 
been shown to help to improve supply chain performance. One contribution 
it can make is by improving information integration 
• Relationship quality with customers is considered to be an important but 
weakly defined field. The environment in which the relationship exists has 
been neglected. This may be an important aspect of multi-country research 
where cultural factors influence the strength of relationships 
• Research is increasingly focusing on agile supply chains rather than lean 
ones. This may be because agile thinking is perceived to be a prerequisite 
for survival in uncertain marketplaces. Hybrid supply chains are sometimes 
proposed as a way of achieving the best of both 
• The concept of postponement repeatedly arises both implicitly and 
explicitly, not least as a way of contributing to hybrid supply chain thinking. 
Postponement refers to delayed product customisation taking place close to 
the customer (Boone et al. 2007) 
• There are recommendations to investigate industry-specific supply chains 
and to perform more research in geographies outside North America and 
Europe. 
 
In summary, current supply chain topics documented from this review of literature 
reviews are: 
1. Supply chain performance, including the application of financial 
measurements 
2. Supply chain sustainability, both environment and social 
3. Supply chain agility, including the contribution of postponement 
4. Supply Chain Management, including the contributions of ICT and 
knowledge management 
5. Closer integration of supply chain partners and the issue of who manages 
the supply chain end-to-end 
6. The need to perform research in the developing world 
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7. The need to get closer to the customer. 
 
This review will now focus on customer/consumer centricity as a lead-in to patient 
centricity. 
 
Consumer centricity 
The Collins English Dictionary (2013) defines “customer” as “a person who buys”  
and “consumer” as “a person or thing that consumes”. Therefore it is customers 
who pay; they may also be consumers but are not always so. Examples of where 
the customer is not the consumer include in-company employee helpdesks and free 
(or free-at-the-point-of-delivery) healthcare services. 
 
However, in supply chain literature the roles of consumer and customer are 
generally conflated unless it is necessary to distinguish between them. For example 
Jüttner, Christopher, & Baker (2007) refer to the need for product variety to “match 
what consumers want to buy”. However, supply chain literature will distinguish the 
roles when it is necessary to emphasise the final customer in the chain and not one 
of the supply chain partners. In these cases, the term “end-consumer” is sometimes 
used to make this totally clear. An example is Thublier, Hanby, & Shi (2010), which 
also refers to “consumer/customer” to highlight the fact that they are referring to a 
person who is both the “end-consumer” and the one paying. 
 
Hence both customer centricity and consumer centricity are discussed in supply 
chain literature. The meaning is generally the same except at times when authors 
find it necessary to distinguish between them.  
 
Historically, delivering what the customer was perceived to want was the limit of 
customer-centricity. As Collin, Eloranta, & Holmström (2009) said, this amounted to 
“cost reduction and fast delivery”, an approach which they identified as originating 
in operations management. Supply chain design has become more sophisticated, 
with for example segmentation into lean, agile and hybrid designs depending on 
product type (Rahimnia & Moghadasian 2010). However, supply chain 
measurement has tended to remain focused on tangible factors such as reliability 
and responsiveness, even though it has been pointed out by Jüttner et al. (2007) 
that improved supply chain efficiency by itself does not increase customer 
satisfaction. Their recommendation was that the supply chain had to “begin with 
the customer”. In order to achieve this it is necessary for supply chain partners to 
know what customers value. 
 
There is a growing body of literature that relates back to before Adam Smith in 
“Wealth of Nations” (1776, referred to in Vargo & Lusch, 2004) wrote that the 
exchange of goods was the measure of a country’s economy. It seems that he chose 
this because it was in line with the socio-political views of the time, and it was a 
departure from the then-accepted view of economists that value is produced only 
when the consumer makes use of an offering. Those who pursue research into pre-
“Wealth of Nations” views refer to this approach as Service-Dominant Logic (SDL) 
and call Smith’s new measure Goods-Dominant Logic (GDL) in contradistinction 
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(Vargo & Lusch 2004; Vargo & Lusch 2008). In SDL, the supply chain provides a 
value proposition but the consumer determines the value of the offering in their 
context (Chandler & Vargo 2011; Ng 2013). In SDL, value is seen as being co-created 
by the customer from the value proposition in context, and so the term “consumer” 
is deprecated as it implies a passive utilisation rather than an active participation. 
 
A framework for the concept of value within SDL has recently been provided by Ng 
& Phillips (2013). In their work they refer to “phenomenal-consciousness value” (P-
C value) as being equivalent to the co-creation of value in context. They mention 5 
facets: the offering, the offering’s affordance (what it provides), the context, the 
agency (the ability for the customer to take action – or from an opposite 
perspective, the lack of constraints on them), and the customer’s resources (skills 
and competencies) (ibid., p.228-229). From these it can be seen that value will 
depend on the context, the customer’s skills and the customer’s ability to take 
action just as much as on the value proposition embodied in the offering. Therefore 
it is recognised that to be customer-centric requires an understanding by supply 
chain partners of customers’ contexts, skills and constraints – an understanding of 
customers’ practices (Grönroos 2008) – while creating their value proposition. 
Further, since the customer’s contexts, skills and constraints are variables outside 
the control of the supply chain partners, then by augmenting the offering’s value 
proposition it may be possible to reduce their variability and so enable customers 
to achieve higher value in use. This is perhaps the most useful aspect of customer-
centricity to focus on because it should lead to increased customer satisfaction. 
 
Healthcare supply chains 
Healthcare supply chains are important contributors to healthcare systems, which 
the World Health Organisation defined as “the organizations, institutions and 
resources that are devoted to producing health actions. A health action is defined 
as any effort, whether in personal health care, public health services or through 
intersectoral initiatives, whose primary purpose is to improve health” (Musgrove et 
al., 2000, p.xi). Theoretically, healthcare supply chains are no different to those in 
any other industry, though it is acknowledged that in practice they “may be 30 
years behind the grocery business in terms of sophistication” (Ebel, Larson, & Shah, 
2012, p.12). Just as in other industries, their function “encompasses every effort 
involved in producing and delivering a final product or service, from the supplier's 
supplier to the customer's customer” (SCC 2012). 
 
One difference that the literature mentions (Pedrosoa & Nakano 2009) is patients 
not having “purchasing decision power”. However, as indicated earlier there are 
supply chains in other industries where this is the case. This is therefore not unique 
to healthcare, though it may be unusual. 
 
There may be two differences, however, which do make healthcare supply chains 
different. The first is the range of external organisations which can affect the supply 
chain. Regulators, payers, patients, physicians and pharmacists are all stakeholders 
who must be considered in supply chain design (Laws 2013a), to which should be 
added Ministries of Health (MoHs) -- there is significant involvement of the public 
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sector in healthcare supply chains. Regulators and MoHs determine the conditions 
under which a drug can enter a market. Payers (insurance companies and MoHs in 
mature markets, MoHs and donors in emerging markets) decide on priorities and 
prices. Physicians and pharmacists judge which drug should be used among the 
range of options. This range of participation alongside the core relationship 
between the supply chain partners and the patient can add complexity, which may 
then impact the clarity of purpose for supply chain partners. 
 
The second is the ultimate objective of healthcare supply chains. While supply 
chain partners in the grocery business may be interested in customer satisfaction, 
healthcare supply chain partners know that the outcome of their work can make 
the difference between life and death. Despite this, a recent literature review on 
the pharmaceutical supply chain (Narayana et al. 2014) determined the four 
dimensions of “final value delivered to the consumer” as being “availability, access, 
affordability and safety”; this suggests that the literature lags practice. One of 
PwC’s series of pharmaceutical reports (Friend et al. 2011) found that one of seven 
“forces” on the industry is “the increasing emphasis on outcomes”. It points out 
that payers want to see both evidence of medicine effectiveness as well as patients 
receiving supporting services to maximise effectiveness. As a result, a trend 
towards “pay for performance” is already emerging and is expected to increase 
(Friend, Arlington, Evans, et al. 2009). 
 
The suggestion that healthcare supply chains are “30 years behind” (Ebel et al. 
2012) the current state of the art brings additional complication to research. This is 
because it cannot be assumed that any research environment will reflect current 
supply chain thinking. It is likely that a healthcare supply chain practitioner, 
especially in the developing world, will have a different level of maturity to that 
expected of a supply chain manager in a retail business. 
 
Patient centricity 
As Musgrove et al. (2000) say of clinical services, “At the centre of service delivery 
is the patient”. The pharmaceutical industry is aiming to support this through the 
provision of patient services, thus improving its value proposition to patients. Such 
services are generically referred to as “beyond the pill” (Laws 2013a; Wenzel et al. 
2013; EyeForPharma 2013; Laws 2013b) in reference to them extending the service 
which the healthcare supply chain partners currently provide through the provision 
of drugs. 
 
These are delivered in two ways. The first is services which are separate from drugs, 
such as Pfizer Integrated Health’s healthcare offerings (Pfizer Integrated Health 
2013) which are aimed at improving employee wellness through health schemes 
provided by companies and unions, and AstraZeneca’s mHealth initiative (Handford 
2013) which will provide personalised support to patients and allow them to record 
their clinical data. 
 
The second is services which are linked to or associated with drugs. Of these, 
perhaps patient adherence (or compliance) is the most favoured at present. As 
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Firlik (2013a) says, “Pharmaceutical companies are interested not only in selling 
pills, but in selling pills that actually work… Doctors intuitively understand the 
critical role that adherence plays in clinical outcomes”. The World Health 
Organisation has endorsed the idea that increasing adherence “may have a far 
greater impact on the health of the population than any improvement in specific 
medical treatments” (Sabate 2003 p.xiii). 
 
What is stopping patients from achieving higher adherence rates than the 50% or 
so commonly reported? (Sabate 2003; Marcus 2013; Brown & Bussell 2011). 
Sabate's report for the World Health Organisation (WHO), “Adherence to Long-
Term Therapies”, identified five interacting dimensions of adherence: 
socioeconomic factors, factors associated with the health care team and system in 
place, disease-related factors, therapy-related factors, and patient-related factors. 
Salmane-Kulikovska & Dobelniece (2012) drew together a wide-ranging list of 
factors affecting adherence, including demographic, socio-economic, socio-
psychological, health status, disease severity, health beliefs, parental example, 
usage information, depression, personal traits, economic and cultural factors. 
 
However, this research is primarily Western in focus and potentially misses factors 
or details which may be localised to other parts of the world. It is recognised that 
patients “in emerging countries, for example, may have substantially different 
wants and preferences in terms of pharmaceutical product taste, texture, package 
size, unit dosing, or services” (Reynolds 2013). While there has been significant 
research into adherence in HIV/AIDS patients in Africa (for example Adewuya et al. 
2010; Skovdal et al. 2011; Murray et al. 2009; Dahab et al. 2008; Roura et al. 2009; 
Weiser et al. 2010; Bisson et al. 2008), the HIV/AIDS focus has been perhaps 90% of 
all such research and therefore it is likely that further important information on 
reasons for non-adherence has not yet been captured. 
 
Through all this it must be remembered that patients create value by their 
practices, and therefore a deep understanding of people's practices must be the 
basis for developing truly patient-centric offerings that will provide patient-
perceived value and satisfaction (Grönroos 2008). This implies a need for more 
research into how drug-related “beyond the pill” offerings can truly improve the 
value propositions of their associated drugs. In the final analysis, this is important 
as making sure drugs are effective (Brake 2013). 
 
Patient-centric healthcare supply chains 
Supply chains can be viewed as value co-creation networks that deliver value 
propositions (Tokman & Beitelspacher 2011). There is now increasing recognition 
that the primary purpose of a supply chain is to deliver customer-perceived value 
and satisfaction (Wong et al. 2012; Stock et al. 2009). Many recent papers (for 
example Hilletofth 2011; Jüttner et al. 2007; Jüttner et al. 2010; Bustinza et al. 
2013; Stank et al. 2012) highlight the need to understand customer needs and then 
make them known to supply chain partners. 
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Firlik said (2013a), “What we need are new ways to improve human motivation to 
take the medications that can prevent [disease] in the first place… The holy grail 
here is to add motivation innovation to the mix, to reach the under-motivated folks 
who represent the most serious risk to poor outcomes”. While this may be valid, 
this omits the possibility that some people, however motivated, are unable to take 
their drugs due to – from an SDL perspective – their context, the constraints on 
them, a lack of resources, or a combination of all three. This should drive a desire 
for supply chain partners to become much more aware of the patient’s real needs 
in order to increase adherence. As Friend et al. said (2011) “[pharmaceutical 
manufacturers must] acquire a much deeper understanding of patients in a world 
where outcomes count for everything”. In part at least, this is because of “shifting 
demand in healthcare towards products accompanied by services, that pushes for 
outcomes-based reimbursement” (Sharp 2013). 
 
In order therefore to move towards genuine patient-centric healthcare supply 
chains, it will be necessary first to gain a deeper understanding of patient needs, 
second to communicate these to supply chain partners, and third to determine how 
and where in the supply chain to make changes to improve value propositions. 
With this approach there is the opportunity to deliver “beyond the pill” solutions 
that improve patient adherence and thus enhance outcomes. Contributors to such 
solutions may include changes to the supply chain and to product design, and may 
require enhanced ICT support. An outcome may be changes to business models. 
These will be considered in the second part. 
 
Conclusions 
This literature review has used the Overseas Development Institute-suggested 
process to gather material from academic and grey literature sources to provide a 
balanced view of the State of the Art in patient-centric healthcare supply chains. 
From this, the following conclusions can be drawn: 
1. Supply chain performance, sustainability and agility are very current topics 
in supply chain research generally. Sustainability includes both 
environmental and social aspects. Agility includes the concept of 
postponement, ie. delaying final product configuration until an appropriate 
point in the supply chain between manufacture and consumption 
2. Current areas of Supply Chain Management focus include ICT and 
knowledge management. The context for both includes the need for closer 
integration of supply chain partners, and one driver for this is to share 
customer-originated information as supply chains are driven to get closer to 
the customer 
3. Getting closer to the customer is another way of referring to increasing 
customer centricity. Customer centricity includes learning about the 
customer’s environment in order to deliver enhanced value propositions 
4. Healthcare supply chains have two features which make them diverse from 
those in other industries: the range of external organisations that can affect 
them and the ultimate objective of making life-and-death interventions. The 
pressures from these features are driving an increased focus on patient 
centricity and outcome-dependent payment 
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5. Patient centricity puts patients at the heart of the healthcare supply chain. 
One way of achieving this is through improving patient adherence as part of 
“beyond the pill” initiatives. While this has been researched in detail for 
some disease types, much more must be done especially in the developing 
world before healthcare supply chains can be truly said to be patient-centric 
6. The World Health Organisation has said, “Access to medication is necessary 
but insufficient in itself for the successful treatment of disease” (Sabate 
2003 p.xiii). A major opportunity exists for research into adherence issues in 
sub-Saharan Africa using Service-Dominant Logic concepts. The aim would 
be for supply chain partners to acquire a much deeper understanding of 
patients’ needs in context and so improve the ability for patients to achieve 
adherence without further interventions. 
 
 
 
2. Implications for the future in sub-Saharan Africa 
This section addresses the second research question, namely: 
 
Based on the State of the Art and thought leadership in this area, what are some 
possible implications for the future in terms of drug product design, drug supply 
chain, ICT enablement and business models in the context of sub-Saharan Africa? 
 
The section builds on the assessment created in the first section for supply chains 
and consumer centricity to identify and analyse the implications for each of the 
four listed areas. It first defines the sub-Saharan African context and ends with 
conclusions. 
 
The sub-Saharan Africa context 
The United Nations (United Nations Statistics Division 2013) defines sub-Saharan 
Africa in this way: 
 
“The designation sub-Saharan Africa is commonly used to indicate all of Africa 
except northern Africa, with the Sudan included in sub-Saharan Africa”. 
 
By this definition, the countries listed in Table 3 are included as per the same 
United Nations source. 
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Table 3 : List of Countries in sub-Saharan Africa (United Nations Statistics Division 
2013)
 
 
Sub-Saharan Africa is a valid exemplar of the developing world. 34 out of 49 
countries defined by the United Nations as being “Least Developed Countries” 
(LDCs) are in the region (UN-OHRLLS 2013). These countries are marked by low 
income, low literacy rates, high population growth, high child mortality rates, and 
reduced life expectancy. The SSA population is almost 1 billion people. It provides a 
set of value-in-context challenges which are likely to include both practical and 
sociological elements. 
 
While it is not possible to get detailed figures for the value of drugs which pass 
through the healthcare supply chains in SSA, several billion dollars per year are 
donated to major healthcare programs such as for malaria and HIV/AIDS. Taking an 
alternative approach to quantifying it, it is estimated that around 5% of Gross 
Domestic Product (GDP) is spent on healthcare in SSA (Kaseje 2006); in 2012 GDP in 
SSA was assessed as being $1.3 trillion (IMF 2013) suggesting that healthcare is 
conservatively a $30 billion business in SSA. Healthcare supply chains in SSA 
therefore provide both a rich vein of information to mine at the patient level in 
order to improve supply chain value propositions, and the potential to make a 
significant impact on people's lives. 
 
Eastern Africa Middle Africa
Sudan Burundi Angola Botswana Benin
Comoros Cameroon Lesotho Burkina Faso
Djibouti Namibia Cape Verde
Eritrea Chad South Africa Cote d'Ivoire
Ethiopia Congo Swaziland Gambia
Kenya Ghana
Madagascar Guinea
Malawi Gabon Guinea-Bissau
Mauritius Liberia
Mayotte Mali
Mozambique Mauritania
Réunion Niger
Rwanda Nigeria
Seychelles Saint Helena
Somalia Senegal
South Sudan Sierra Leone
Uganda Togo
Zambia
Zimbabwe
orthern 
Africa
Southern 
Africa
Western 
Africa
Central African 
Republic
Democratic 
Republic of the 
Congo
Equatorial 
Guinea
Sao Tome and 
Principe
United 
Republic of 
Tanzania
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Implications for drug product design 
This is primarily a patient centricity issue. When considering drug product design, it 
is important to understand drug use in the developing world. PwC’s 2011 report, 
Supplying the Future (Friend et al. 2011), provided some insights into this. It said, 
“The choices they make are often based on different values from those that 
influence the design of products and services intended for consumption in the 
developed world. Cost and the ability to buy on a daily or weekly basis are more 
important than convenience, for example”. This example of packaging and pricing 
drugs based on daily personal cashflow rather than on a periodic (eg. monthly) 
discounted lump sum basis fits with the regularly heard expression, “30 [currency 
units] a month is too much, but 1 a day is affordable”. 
 
The report goes on to say that it is important that pharmaceutical companies 
should “understand the needs of patients living in these countries and tailor its 
offerings accordingly”. This could be package size as indicated above. It could also 
involve offerings that are easier to consume in SSA conditions, such as through 
sublingual (SL) administration rather than as tablets that must be taken with water.  
 
While the need is clearly summed up by the PwC report, and obvious examples can 
be multiplied, what is urgently required now is field research into patient needs in 
the developing world. It is important to determine what is valued by patients in 
resource-poor environments. In Service-Dominant Logic terms, this means 
understanding what alternative value propositions would provide greater value-in-
context for patients at the point of consumption (value co-creation). Changes in this 
area could make significant improvements to patient adherence, so improving 
patient outcomes. 
 
Implications for drug supply chains 
Both patient centricity and supply chains contribute to this topic. The implications 
for drug design above may also be delivered selectively/wholly and 
temporarily/permanently by changes to the supply chain. Postponement (Boone et 
al. 2007) could be one basis for such changes. Taking the earlier example, if a drug 
is delivered in a form that requires it to be taken with water then a product design 
change to improve patient adherence could be to deliver it in SL form. An 
equivalent supply chain design change could be to provide a bottle of water as part 
of the drug prescription. Depending on the preferences of pharmaceutical 
companies, donors, regulators and MoHs, this could be a permanent or temporary 
(pending drug redesign) change. It could also be selective, only being provided at 
certain times of year or to particular sub-sections of the population. 
 
Ideally the needs of patients would also be taken into account. As with the 
implications on drug product design, this would require research into patient 
preferences in the developing world to understand their preferred value 
proposition(s). Service-Dominant Logic thinking would be a valid approach for this. 
Research into the relative improvement in patient adherence of each option may 
also provide useful information when choosing the approach. 
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Such interventions would potentially require closer integration of supply chain 
partners in order for them to determine the optimum point of postponement and 
the details of the arrangements. For example, if a bottle of water is to be “inserted” 
into the supply chain for each pack of a certain drug, is that done at the central 
warehouse, the regional warehouse, the district store or the health facility? Who is 
responsible for purchasing the water? Is it ordered through the normal healthcare 
supply chain processes? These and other questions, discussed by supply chain 
partners, will determine the most beneficial and cost-effective approach for such 
interventions. 
 
More widely, it is evident from the review of supply chain literature that in general 
there is a need for more healthcare supply chain-specific research and more 
geography-specific research. The majority of supply chain research has been 
conducted in North America and Europe on industrial supply chains; healthcare 
supply chains in sub-Saharan Africa are under-researched. 
 
Implications for ICT enablement 
Information and Communications Technology has transformed many businesses 
and has contributed to improvements in supply chain processes in many industries, 
most notably through improved communication between supply chain partners (Shi 
& Yu 2013; Simangunsong et al. 2012; Gligor & Holcomb 2012). There has been 
limited application of ICT to healthcare supply chains in the developing world, at 
least downstream from central warehouses where paper-based processes still 
predominate. While there are some notable examples of how ICT can enable more 
agile processes in healthcare supply chains (for example Barrington et al. 2010), 
there is still much that can be done. As mobile phones and mobile network 
coverage become more ubiquitous in the developing world (for example Lee et al. 
2012), the opportunity increases to exploit them to support stock management, 
stock ordering, vehicle tracking and other supply chain processes. 
 
In addition, there is the opportunity to make use of ICT to improve patient 
centricity and to deliver additional patient-related services. There are some 
examples of this in sub-Saharan Africa and elsewhere, such as using SMS messages 
sent to patients to remind them to take their drugs (Pop-Eleches et al. 2011; Sabate 
2003). In sub-Saharan Africa, in line with perceived health priorities, these have 
primarily focused on HIV/AIDS and associated diseases. Such reminders have been 
shown to be effective if the patient has the resources required to take the drugs. 
There may be the potential to automate the setting of alarms and reminders using 
information linked from drug packaging using an Internet of Things (IoT) approach 
(Wikipedia 2013; European Union 2013). Other opportunities for using IoT may 
include controlling daily drug dispensers, recording health indicators either for 
personal use or for sharing with health staff, and remote patient support. While 
such ideas have been trialled in the developed world (see Couturier et al. 2012 for a 
review of experiences), there is scope to research their application and 
acceptability in the developing world. This would potentially encourage 
pharmaceutical manufacturers to engage in relevant and visible “beyond the pill” 
initiatives. 
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Based on the results of the literature reviews, it would seem that there are 
opportunities to make more use of ICT in healthcare supply chains, not least in the 
developing world where mobile communications penetration is widespread. 
Therefore research into the most effective approaches should identify ways to 
improve patient care, reduce costs and increase effectiveness. 
 
Implications for business models 
There is little agreement on the definition of the term “business model”, but it is 
considered to incorporate the four themes of strategic choices, the value network, 
creating value and capturing value (Ng & Briscoe 2012).  Ng and Briscoe also 
indicate that new business models usually occur as a result of either innovation or 
new technology, to which could also be added new external requirements. 
 
The conclusions from the literature reviews plus the implications listed above 
indicate that a number of innovations, new technologies and new external 
requirements are emerging in the healthcare supply chain including: 
• Increasing customer centricity, including a desire for improved patient 
adherence 
• Pressure to deliver outcomes 
• “Beyond the pill” expectations 
• Changes to drug design and/or enhancements through postponement 
• Increasing need for supply chain agility 
• Closer integration of supply chain partners 
• Opportunities for improved use of ICT including mobile technologies and 
Internet of Things 
• Constant pressure on cost and efficiency. 
 
Each of these could therefore have implications on business model design for 
pharmaceutical manufacturers, for MoHs and for other supply chain partners. 
Outcome-based contracts (Ng & Briscoe 2012), focused on outcomes rather than 
inputs, may be expected in healthcare supply chains before too long (Friend, 
Arlington, Pisani, et al. 2009). This should lead to pharmaceutical manufacturers 
working much more closely with the rest of the healthcare supply chain and with 
regulators. This should in turn lead to improved use of ICT to facilitate enhanced 
communications along the supply chain, which will also assist with cost reductions 
while contributing to agility. 
 
Changes to drug design could potentially change business models if they lead to a 
differentiated approach to supplying the developing world. At present, 
pharmaceutical manufacturers sell into the developing world what they have 
already created for mature markets. Therefore if they begin to see the developing 
world as a major new market that requires different products – as, for example, 
automotive manufacturers have done for some time – then it could lead to new 
business divisions as with GSK’s Developing Countries and Market Access operating 
unit, for example (Learmouth 2011). And as with the automotive industry, it may 
then lead to developing world products being introduced back into mature markets 
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to serve appropriate market segments; this so-called “reverse innovation” can be 
very disruptive to established markets, thus increasing value capture for companies 
that do this successfully. 
 
The increasing need for improved supply chain agility could see greater use of third-
party logistics companies for healthcare supply chains in the developing world. At 
present, the majority of public sector healthcare supply chain processes are 
operated in-house by MoHs, with perhaps only central warehousing managed by a 
third party either as an outsourcing contract or with contract staff (Dowling 2011). 
It is acknowledged that MoHs are not necessarily best placed to continue this role 
for the longer term, as a result of skills issues and staff shortages (Brown 2011). 
Outsourcing of larger sections of the supply chain could therefore potentially 
improve services while reducing costs. Such an approach could begin to address the 
30-year lag in healthcare supply chain practices compared to other industries. 
Research in this area could be valuable. 
 
Conclusions 
It is clear from the analysis in this section that there are indeed implications in the 
four focus areas. In order to achieve higher patient-centricity, drug design can be 
enhanced, supply chains can be improved, and ICT can be used more effectively. 
Business model changes can be expected as a result. 
To achieve this it will be necessary to perform research into the issues around 
patient adherence in the resource-poor environments that predominate in sub-
Saharan Africa. This should be the precursor to change, and should inform it. 
 
 
 
Overall Conclusions and Recommendations 
There are a number of conclusions that can be drawn from the answers to the two 
questions asked at the start of this report. At a high level, it is clear that healthcare 
supply chains in the developing world cannot stay as they are if the internal and 
external pressures on them are to be accommodated. The challenge therefore is to 
determine in what ways they could or should change. 
 
If healthcare supply chains are to remain true to their aims then the benefits of any 
changes should be accrue first to the patient. Consumer centricity is an emerging 
theme of supply chains in general but patients should naturally be at the heart of 
healthcare supply chains. 
 
On this basis, it is recommended that Service-Dominant Logic-focused research into 
patient adherence in sub-Saharan Africa should be a starting point. It will 
determine what patients need that supply chains can deliver, and provide a basis 
for outcome-based contracts since patient adherence is core to understanding and 
improving outcomes. 
 
With this information as a base, possible changes can be considered. Some changes 
will enhance services to patients, such as drug modifications to help improve 
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patient adherence or the use of IoT concepts for monitoring or reminders. Others 
will reduce costs or improve effectiveness in the supply chain, but without 
impacting patients because patient needs will be central to the plans. Examples of 
these may be increased use of ICT for supply chain knowledge management to 
enhance agility, supply chain cooperation to support outcome-based contracts, and 
increased use of outsourcing to reduce costs. 
 
Whatever changes are eventually made, the focus must be the patient. To this end, 
the question which must first be answered is, why is patient adherence in sub-
Saharan Africa so low? From this knowledge, all other changes can flow. 
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